Bioactive molecule-derived covalent organic frameworks as biocompatible scaffolds for targeted AKR1B10 inhibition in alcoholic liver disease
{{output}}
Alcoholic liver disease (ALD) incidence is rising globally, yet effective targeted therapies remain elusive. In recent years, bioactive molecules have gained prominence in liver disease research. However, no natural inhibitors targeting key drivers of ALD have... ...
